相关实验视频
Updated: Jun 28, 2025

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.2K
抑制生长分化因子-15通过调节MAPK/ERK信号通路来抑制前列腺癌
Minggen Yang1, Miaolin Guo2, Chenqiang Su3
1Department of Urology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, Fujian, China. yangminggen@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|April 23, 2024
概括
增长分化因子15 (GDF15) 在前列腺癌的进展中起着关键作用. 抑制GDF15抑制了瘤生长,但C16PAF逆转了这些效应,突出了GDF15作为潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌是男性常见的恶性瘤.
- 增长分化因子15 (GDF15) 与各种癌症有关,但其在前列腺癌中的作用尚不清楚.
研究的目的:
- 研究GDF15在前列腺癌中的调节功能.
- 探索针对GDF15.5的治疗潜力.
主要方法:
- 在前列腺癌细胞中创建了GDF15敲击和过度表达模型.
- 用RT-PCR,西部斑点,CCK8,Transwell,伤口愈合和流细胞计进行了分析.
- 用裸体小鼠的转移性瘤模型来评估体内瘤的生长.
主要成果:
- 在前列腺癌组织和细胞中观察到高GDF15表达.
- GDF15敲击抑制了细胞增殖,入侵,迁移,上皮细胞-介质细胞过渡 (EMT) 和瘤生长,同时促进了细胞亡.
- C16PAF抵消了GDF15敲击的作用,逆转了瘤进展和EMT的抑制.
结论:
- GDF15显著影响前列腺癌的进展.
- C16PAF可以逆转由GDF15抑制引起的抗瘤作用.
- GDF15是前列腺癌治疗和预防的有前途的治疗标.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K

